Standardized SEC financial data for Fresh Tracks Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000819050 · Biological Products, (No Diagnostic Substances).
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | $10.9M | $7.9M | $1.8M | $404K | $6.9M | $8.0M |
| R&D expense | $13.0M | $20.2M | $11.2M | $28.2M | $14.0M | $3.2M |
| SG&A expense | $6.4M | $12.2M | $11.6M | $12.4M | $14.4M | $11.2M |
| Operating income | -$8.5M | -$24.5M | -$21.0M | -$40.2M | -$21.5M | -$6.4M |
| EBITDA | -$8.3M | — | — | — | — | — |
| Interest expense | $1.1M | $2.1M | $0 | $69K | $9K | $5K |
| Income tax | $0 | — | — | — | — | — |
| Net income | — | -$23.9M | -$20.9M | -$39.5M | -$21.1M | -$5.7M |
| EPS (diluted) | — | — | $-0.85 | $-22.12 | $-7.51 | $-1.06 |
Standardized from Fresh Tracks Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000819050/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000819050/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"